Consider Subcutaneous Insulin to Manage DKA
July 2022
You’ll hear renewed debate about the optimal insulin regimen for treating diabetic ketoacidosis (DKA) in adults.
A recent retrospective study suggests that subcutaneous insulin, instead of IV, reduces ICU admissions...with no difference in hypoglycemia.
This adds to other limited data suggesting subcutaneous insulin is safe and effective for mild to moderate DKA.Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote